Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jan 15;11(2):e41981.
doi: 10.1016/j.heliyon.2025.e41981. eCollection 2025 Jan 30.

Alpha synuclein and inflammaging

Affiliations
Review

Alpha synuclein and inflammaging

Geneviève L Putnam et al. Heliyon. .

Abstract

The α-synuclein protein is an established molecule in Lewy body pathology, especially Parkinson's disease (PD). While the pathological role of α-synuclein (α-syn) in PD has been well described, novel evidence may suggest that α-syn interacts with inflammasomes in response to aging. As age is an inevitable physiological state and is also considered the greatest risk factor for PD, this calls for investigation into how α-syn, aging, and PD could be linked. There is a growing amount of data regarding α-syn normal function in the body that includes involvement in cellular transport such as protein complexes assembly, vesicular trafficking, neurotransmitter release, as well as immune cell maturation. Regarding abnormal α-syn, a number of autosomal dominant mutations have been identified as causes of familial PD, however, symptomatology may not become apparent until later in life due to compensatory mechanisms in the dopaminergic response. This potentially links age-related physiological changes not only as a risk factor for PD, but for the concept of "inflammaging ". This is defined as chronic inflammation that accompanies aging observed in many neurodegenerative pathologies, that include α-syn's ability to form oligomers and toxic fibrils seen in PD. This oligomeric α-syn stimulates pro-inflammatory signals, which may worsen PD symptoms and propagate chronic inflammation. Thus, this review will explore a potential link between α-syn's role in the immune system, inflammaging, and PD.

Keywords: Aging; Inflammaging; Inflammation; Parkinson's disease; α-synuclein.

PubMed Disclaimer

Conflict of interest statement

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Robert Maitta is Associate Editor for Heliyon. All authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Representation of monomeric α-synuclein structure with most common point mutations in relation to the N-terminal domain. For reference serine residue 129 which undergoes phosphorylation in the C-terminal domain is shown. This figure is adapted from Refs. [165,166]. Graph shows the three known regions of α-syn. Amino terminus binds membrane structures, central domain is mostly freely accessible and carboxy terminus interacts with protein complexes.
Fig. 2
Fig. 2
Diagram of α-syn interactions with inflammasome and inflammatory pathways in the cell. This includes activation of TLR-mediated pathways, gene expression, NLRP3 and the inflammasome, ROS and increase in inflammatory cytokines, activation of the unfolded protein response (UPR) and chronic endoplasmic reticulum (ER) stress (ERS) pathway, with feedback and communication among pathways that can be self-amplified with additional α-syn aggregation.

Similar articles

References

    1. Dexter D.T., Jenner P. Parkinson disease: from pathology to molecular disease mechanisms. Free Radic. Biol. Med. 2013;62:132–144. - PubMed
    1. World Health Organization Parkinson's disease. 2023. https://www.who.int/news-room/fact-sheets/detail/parkinson-disease
    1. National Institutes of Health Parkinson's disease: challenges, progress, and Promise. 2023. https://www.ninds.nih.gov/current-research/focusdisorders/parkinsonsdise...
    1. G.B.D.P.s.D. Collaborators Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):939–953. - PMC - PubMed
    1. Ou Z., Pan J., Tang S., Duan D., Yu D., Nong H., Wang Z. Global trends in the incidence, prevalence, and years lived with disability of Parkinson's disease in 204 countries/territories from 1990 to 2019. Front. Public Health. 2021;9 - PMC - PubMed

LinkOut - more resources